A newly detected coronavirus variant is on the rise in England, with the virus believed to be an offshoot of Delta.
According to a briefing from the UK Health Security Agency, released on Friday, “a Delta sublineage newly designated as AY.4.2 is noted to be expanding in England”, with the body adding that the variant is being monitored and assessed.
The report states that in the week beginning 27 September – the last week for which complete sequencing data was available – AY.4.2 accounted for about 6% of sequenced coronavirus cases and is “on an increasing trajectory”.
AY.4.2 contains two mutations in its spike protein, called A222V and Y145H. The spike protein sits on the outside of the coronavirus and helps the virus to enter cells.
However, Ravi Gupta, a professor of clinical microbiology at the University of Cambridge, told the Guardian these mutations were not of particular concern. “A222V has been seen in other lineages of Delta,” he said. “It doesn’t have a really large effect on the virus.”
Gupta added similar mutations to Y145H had been seen in the Alpha variant and other variants. While these appear to have an effect on the binding between antibodies and the virus, Gupta said the effect was, at most, modest.
“But in my mind, these are not really significant mutations,” he said. “We need to look further at what the non-spike mutations are.”
In the past, new Covid variants have fuelled large surges in the number of cases – the Alpha variant played a key role in rising cases last winter, while the Delta variant took off and led to sharp increases in the spring. Daily Covid cases in England are rising once again: 39,624 new Covid cases were reported on Saturday, the highest figure since late July.
According to the Financial Times, Dr Jeffrey Barrett, the director of the Covid-19 Genomics Initiative at the Wellcome Sanger Institute in Cambridge, and Prof Francois Balloux, the director of the University College London Genetics Institute, have suggested AY.4.2 could be 10-15% more transmissible than the original Delta variant.
However, they urged caution. “Britain is the only country in which it has taken off in this way and I still would not rule out its growth being a chance demographic event,” Balloux told the FT.
Balloux told the Guardian the new variant was unlikely to be behind the recent rise in cases.
“Its potential higher transmissibility could at this stage only explain a tiny fraction of additional cases,” he said. “It’s around 10% frequency [now], and assuming it may be 10% more transmissible, that would only explain an additional 1% extra infections [every five or so days].”
Gupta said the focus on a new variant was missing the point, noting a number of other important factors including the slow rollout of jabs to older children. According to official figures, vaccination rates among 12- to 15-year-olds were about three times lower in England than Scotland.
“We shouldn’t be blaming the virus for what is going on in the UK,” said Gupta. “It is because we have fundamentally failed to control transmission, and that is because kids are vulnerable, they have not been vaccinated, they are back at school, they are spreading virus among themselves and they are feeding it into their families.”
News
Popular Weight-Loss Drugs Like Ozempic Linked to Lower Breast Cancer Risk
Ozempic and similar weight-loss drugs were linked to a striking 30% reduction in breast cancer risk in a study of more than 110,000 women. Popular weight-loss and diabetes medications such as Ozempic, Wegovy, Mounjaro, [...]
Stanford Scientists Discover Explosive New Type of Immune Cell
Scientists studying the remarkable regenerative abilities of planarian flatworms have uncovered a previously unknown type of immune cell with an unusually destructive defense strategy. What if an immune cell could wipe out nearby threats [...]
Big Pharma-backed SonoThera sounds off with $125M series B for bubble-based genetic delivery
Bay Area biotech SonoThera is bubbling to a clinical boil after raising a $125 million series B with the backing of some of the biggest names in pharma. Vida Ventures led the raise, with the venture [...]
Joint initiative of 5 EU countries calls for ‘unified approach’ to pharma framework amid US drug pricing pressure
With drug pricing pressure building from the U.S., a healthcare-focused consortium of five European countries is calling for a “unified approach” to strengthen Europe’s pharmaceutical framework and access to innovative medicines. Belgium, the Netherlands, [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Molecular Manufacturing: The Future of Nanomedicine – New book from NanoappsMedical Inc.
This book explores the revolutionary potential of atomically precise manufacturing technologies to transform global healthcare, as well as practically every other sector across society. This forward-thinking volume examines how envisaged Factory@Home systems might enable the cost-effective [...]
NanoMedical Brain/Cloud Interface – Explorations and Implications. A new book from Frank Boehm
New book from Frank Boehm, NanoappsMedical Inc Founder: This book explores the future hypothetical possibility that the cerebral cortex of the human brain might be seamlessly, safely, and securely connected with the Cloud via [...]
New book from Nanoappsmedical Inc. – Global Health Care Equivalency
A new book by Frank Boehm, NanoappsMedical Inc. Founder. This groundbreaking volume explores the vision of a Global Health Care Equivalency (GHCE) system powered by artificial intelligence and quantum computing technologies, operating on secure [...]
UCLA Scientists Uncover a “Hidden Weakness” in Some of the World’s Deadliest Cancers
A new study has uncovered an unexpected vulnerability in some of the deadliest cancers. Researchers at UCLA have identified a previously hidden weakness in some of the most aggressive cancers, pointing to a possible new way [...]
AI-designed universal coronavirus vaccine clears first human trial
Key Takeaways Super-Antigen Technology: Uses AI and machine learning to analyze viral genomes, creating a single vaccine that targets essential features across entire virus families, including coronaviruses and Ebola. Human Trials & Safety: Phase [...]
Researchers Discover a Hidden Vitamin D Problem That Persists Year-Round
A new study suggests that some groups may not experience the expected seasonal boost in vitamin D levels, even during the sunniest months of the year. Many people assume that spending more time outdoors [...]
Researchers Solve the Mystery Behind a Billion-Dollar Dental Implant Disease
Researchers have uncovered why a common and costly dental implant infection often resists antibiotics. Dental implants have helped tens of millions of people regain a full set of stable, functional teeth, something traditional dentures [...]
Nanoparticles inspired by lung fluid improve therapies targeting respiratory system
The CIC biomaGUNE Center for Cooperative Research in Biomaterials has developed pulmonary surfactant nanoparticles (the blend of lipids and proteins that line the alveoli and enables breathing), which are encapsulated [...]
Scientists Finally Uncover How a “Forever Chemical” Causes Birth Defects
PFDA, a PFAS “forever chemical,” can cause craniofacial birth defects by disrupting retinoic acid regulation during fetal development, revealing the first clear molecular mechanism behind the link. Researchers have long linked perfluoroalkyl and polyfluoroalkyl substances (PFAS), [...]
Scientists Have Discovered These Deadly Parasites Are Secretly Swapping DNA
Leishmania parasites appear to evolve through widespread genetic exchange, reshaping assumptions about how they adapt and spread. A parasite long thought to spread mostly by cloning itself may be far more genetically dynamic than [...]
Stanford’s Revolutionary New Microscope Reveals Living Cells in Stunning Detail
Stanford researchers have developed a microscope that can show how nanostructures interact inside living cells at the highest resolution achieved so far. The view into living cells just got better. Stanford researchers have merged [...]















